viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Clonazepam
keemiline struktuur
Kaubanduslikud nimed erinevates maades
Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist
Clonazepamum
Poola
Iktorivil
Rootsi
Kriadex
Mehhiko
Ravotril
Tšiili
Rivotril
Araabia Ühendemiraadid, Austraalia, Hispaania, Holland, Iirimaa, Kolumbia, Poola, Prantsusmaa, Saksamaa, Saudi Araabia, Suurbritannia, Sveits, Ungari, uus-Meremaa
Viited : Clonazepam
tüüp
avaldamine
939
ajaleht
Gilbar PJ, Groves CF.
Visual compatibility of total parenteral nutrition solution (Synthamin 17 Premix*) with selected drugs during simulated Y-site injection.
Aust J Hosp Pharm 1994 ; 24: 167-170.
1189
ajaleht
Nation RL, Hackett LP, Dusci LJ.
Uptake of clonazepam by plastic intravenous infusion bags and administration sets.
Am J Hosp Pharm 1983 ; 40: 1692-1693.
1246
ajaleht
Hooymans PM, Janknegt R, Lohman JJHM.
Comparison of clonazepam sorption to polyvinyl chloride-coated and polyethylene-coated tubings.
Pharm Weekbl [Sci] 1990 ; 12: 188-189.
1508
ajaleht
Voirol P, Berger-Gryllaki M, Pannatier A, Eggimann P, Sadeghipour F.
Visual compatibility of insulin aspart with intravenous drugs frequently used in ICU.
EJHP 2015 ;22:123-124.
2115
ajaleht
Schneider JJ, Good Ph, Ravenscroft PJ,.
Effect of tubing on loss of clonazepam administered by continuous subcutaneous infusion.
J Pain Symptom Manage 2006 ; 31, 6: 563-567.
2217
ajaleht
Guchelaar H.J, Hartog M.E.
De stabiliteit van clonazepaminjectievloeistof.
Ziekenhuisfarmacie 1997 ; 13, 1: 21-23.
3184
Labor
Hyaluronidase (Hyalase®) - Summary of Product characteristics.
CP Pharmaceuticals 2005
3617
Labor
Hyaluronidase (Hyalase®) - Summary of Product Characteristics
Wockhardt 2011
3728
ajaleht
Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B.
Visual compatibility of defibrotide with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3823
ajaleht
Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R.
Compatibilité physique de médicaments administrés dans l’unité de soins intensifs
Pharmactuel 2015 ; 48, 3 : 146-152.
3976
ajaleht
Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B.
Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
Mentions Légales
